ConductScience.org, home

Trial · NCT05825235

Registered outcomes71

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAnhedonia symptomsBaselineTotal Snaith Hamilton Anhedonia Pleasure (SHAPS) self-report scale scores. Higher scores equal more severe anhedonoa. Score range 14-56
PrimaryAnhedonia symptomsMonth 1Total SHAPS self-report scores. Higher scores equal more severe anhedonoa. Score range 14-56
PrimaryAnhedonia symptomsMonth 2Total SHAPS self-report scores. Higher scores equal more severe anhedonoa. Score range 14-56
PrimaryAnhedonia symptomsMonth 3Total SHAPS self-report scores. Higher scores equal more severe anhedonoa. Score range 14-56
PrimaryAnhedonia symptomsMonth 4Total SHAPS self-report scores. Higher scores equal more severe anhedonoa. Score range 14-56
PrimaryAnhedonia symptomsMonth 5Total SHAPS self-report scores. Higher scores equal more severe anhedonoa. Score range 14-56
PrimaryAnhedonia symptomsMonth 6Total SHAPS self-report scores. Higher scores equal more severe anhedonoa. Score range 14-56
SecondaryCore depression symptomsbaselineHamilton Depression Rating Scale-6 (HDRS6) scores (subscale of HDRS-17)
SecondaryCore depression symptomsMonth 1HDRS6 scores (subscale of HDRS-17)
SecondaryCore depression symptomsMonth 2HDRS6 scores (subscale of HDRS-17)
SecondaryCore depression symptomsMonth 3HDRS6 scores (subscale of HDRS-17)
SecondaryCore depression symptomsMonth 4HDRS6 scores (subscale of HDRS-17)
SecondaryCore depression symptomsMonth 5HDRS6 scores (subscale of HDRS-17)
SecondaryCore depression symptomsMonth 6HDRS6 scores (subscale of HDRS-17)
SecondaryEcological momentary assessmentsbaseline
Number of steps/day, movement pattern distribution over the day, walking distance, time spent in light, moderate and intense physical activity, resting heart rate, blood oxygen saturation, heart rate variability (stress scores), sleep latency (time to fall asleep), sleep awakening (how often you wake up during the night), wakefulness (time in minutes awake during a night), time in deep sleep, sleep efficiency (time asleep vs. total time in bed). All variables are measured using activity meters.
SecondaryEcological momentary assessmentsMonth 1By using activity meters, we will analyze relevant outcomes related to physical activity, sleep, and heart rate
SecondaryEcological momentary assessmentsMonth 2By using activity meters, we will analyze relevant outcomes related to physical activity, sleep, and heart rate
SecondaryEcological momentary assessmentsMonth 3By using activity meters, we will analyze relevant outcomes related to physical activity, sleep, and heart rate
SecondaryEcological momentary assessmentsMonth 4By using activity meters, we will analyze relevant outcomes related to physical activity, sleep, and heart rate
SecondaryEcological momentary assessmentsMonth 5By using activity meters, we will analyze relevant outcomes related to physical activity, sleep, and heart rate

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05825235/registered